It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …

Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

Введение В короткой преамбуле хочется предпослать этому доку менту несколько
определяющих позиций: Принятие в 2003 и 2006 годах съездами ВНок Нацио 1 …

placebo-controlled studies. Nonetheless, amiodarone is approved for use against VT and
VF by most regulatory agencies worldwide and has a high profile as a useful drug. 21 Its …

The clinical outcome of 52 consecutive patients with hypertrophic cardiomyopathy who
developed paroxysmal (< 1 week) or established (≥ l week) atrial fibrillation between 1960 …

Programmed cell death or apoptosis is broadly responsible for the normal homeostatic
removal of cells and has been increasingly implicated in mediating pathological cell loss in …

Purpose: To assess the incidence of amiodarone-mediated aggravation of ventricular
tachyarrhythmias or the development of new arrhythmias, such as torsade de pointes, in …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Amiodarone is an iodinated benzofuran derivative 1'1 that represents a new and extremely
effective therapy for certain life-threatening cardiac rhythm disturbances. There are …